Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2

NCT00050726 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

620

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Interleukin-2

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)